Prostate cancer trials recruiting in California

All Prostate cancer trials nationally

Cities in California

Recruiting trials in California

• 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
  NCT07145177 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: San Francisco
• 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer
  NCT07219147 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Duarte
• 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
  NCT06706921 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• 64Cu-GRIP B in Patients With Advanced Malignancies
  NCT05888532 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
  NCT04868604 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: Stanford
• 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
  NCT04857502 · Phase: Early Phase 1 · Ages: No age limits stated · Sex: Male · California: Los Angeles
• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
  NCT06925737 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Duarte, Irvine, La Jolla, Long Beach
• A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
  NCT06863272 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Orange, San Francisco
• A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
  NCT07103018 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: San Francisco
• A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
  NCT05932862 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Fountain Valley
• A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
  NCT05914116 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Santa Monica
• A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
  NCT06785636 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: Fountain Valley, Los Alamitos
• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
  NCT07005154 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: San Diego
• A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT06879041 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Palo Alto, San Diego
• A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer
  NCT06736054 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Irvine
• A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
  NCT07226986 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
  NCT06888102 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
  NCT04729114 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Anaheim, Santa Rosa
• A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
  NCT05593497 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: West Los Angeles
• A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07719361 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
  NCT06778863 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Sacramento, San Francisco
• A Study of DB-1310 in Advanced/Metastatic Solid Tumors
  NCT05785741 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Sacramento, Santa Monica
• A Study of DM002 in Patients With Advanced Solid Tumors
  NCT06751329 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  NCT06842498 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Los Angeles, San Francisco
• A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
  NCT06172478 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte
• A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
  NCT06465069 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, La Jolla, Los Angeles
• A Study of LY4257496 in Participants With Cancer (OMNIRAY)
  NCT07114601 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Santa Monica, Stanford
• A Study of MGC026 in Participants With Advanced Solid Tumors
  NCT06242470 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Study of MT-4561 in Patients With Various Advanced Solid Tumors
  NCT06943521 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
  NCT06952803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: La Jolla, Los Angeles, San Diego, San Luis Obispo
• A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
  NCT03460977 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Anaheim, Duarte
• A Study of NX-1607 in Adults With Advanced Malignancies
  NCT05107674 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Los Angeles, San Francisco
• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
  NCT06136650 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Irvine, Los Angeles, Orange, Palo Alto
• A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT07225946 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Fountain Valley, La Jolla, Los Alamitos, Los Angeles
• A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
  NCT07164443 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: La Jolla, Los Angeles, San Francisco
• A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
  NCT05652686 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Los Angeles
• A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
  NCT06531499 · Phase: Phase 1 · Ages: 18 Years to 100 Years · Sex: Male · California: Los Angeles, Palo Alto
• A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT06533644 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Sacramento
• A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
  NCT06844383 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Duarte, La Jolla
• A Study of Tarlatamab for People With Prostate Cancer
  NCT07111507 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: San Diego, San Francisco
• A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
  NCT07244341 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: La Jolla
• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
  NCT07213674 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Duarte, Fullerton, Orange, San Francisco
• A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07581184 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Irvine
• A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
  NCT05751434 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Durate, Los Angeles
• A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
  NCT06067841 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Palo Alto
• A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
  NCT06764485 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Anaheim, La Jolla, Los Alamitos, Los Angeles
• A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
  NCT06440005 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
  NCT06609005 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: Newport Beach, Orange
• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  NCT06629779 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Anaheim, Fountain Valley, Glendale, Laguna Hills
• A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT07287150 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Los Angeles, San Francisco
• A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
  NCT04503265 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
  NCT05125016 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: Palo Alto
• A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
  NCT03972657 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Santa Monica
• A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
  NCT07336446 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: Duarte, San Francisco
• AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)
  NCT07285694 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: Duarte, Los Angeles, San Francisco
• ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
  NCT06579417 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · California: San Diego, San Francisco
• AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
  NCT07611110 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Duarte, Irvine, Newport Beach, San Francisco
• Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
  NCT05113537 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
  NCT06173362 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Sacramento
• Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
  NCT05422911 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• Access to Genetic Testing in Underserved Patients With Cancer
  NCT06422455 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Active Surveillance for Cancer of the Prostate (ASCaP)
  NCT00949819 · Phase: Not specified · Ages: 30 Years to 85 Years · Sex: Male · California: Los Angeles
• An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
  NCT07185165 · Phase: Phase 2 · Ages: 18 Years to 90 Years · Sex: Male · California: Los Angeles
• An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
  NCT05939414 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: Male · California: Los Angeles, Palo Alto, San Francisco
• Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
  NCT06235697 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Antioch, Dublin, Fremont, Fresno
• Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
  NCT05869682 · Phase: Phase 2 · Ages: 60 Years and older · Sex: Male · California: Duarte
• COMPASS Study for Metastatic Castration-resistant Prostate Cancer
  NCT07050433 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · California: San Francisco
• Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
  NCT05806515 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Arroyo Grande, Burbank, Carmichael, Duarte
• Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
  NCT04038502 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: West Los Angeles
• Clinical Trial of Approaches to Prostate Cancer Surgery
  NCT05155501 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: Male · California: Duarte
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · California: Arroyo Grande, Bakersfield, Burbank, Carmichael
• Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
  NCT04763980 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · California: San Francisco
• Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
  NCT07164027 · Phase: Early Phase 1 · Ages: 18 Years to 90 Years · Sex: Male · California: Los Angeles
• Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
  NCT07054346 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: San Francisco
• Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies
  NCT06907446 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · California: Sacramento
• Customized TULSA-PRO Ablation Registry
  NCT05001477 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · California: West Hills
• DESTINY-PANTUMOUR04
  NCT07124000 · Phase: Not specified · Ages: 18 Years to 130 Years · Sex: All (male and female) · California: San Diego
• Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
  NCT05804318 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · California: Duarte, Irvine
• Distance-Based Exercise to Preserve Function and Prevent Disability
  NCT07059884 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Dublin, Fremont, Fresno, Modesto
• Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
  NCT06592924 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Anaheim, Arroyo Grande, Baldwin Park, Bellflower
• Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
  NCT07517198 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
  NCT06257693 · Phase: Phase 1 · Ages: 21 Years and older · Sex: Male · California: Fresno, San Francisco
• Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
  NCT05983432 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Beverly Hills, Duarte, Irvine, Orange
• Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
  NCT07080242 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Glendale, Long Beach, Los Angeles, San Francisco
• Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
  NCT06613100 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: San Francisco
• Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
  NCT05948657 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · California: Los Angeles, San Francisco
• FOG-001 in Locally Advanced or Metastatic Solid Tumors
  NCT05919264 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Palo Alto, San Francisco, Santa Monica
• First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
  NCT07332455 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: La Jolla
• First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
  NCT06217822 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte
• Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer
  NCT06178354 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · California: Sacramento
• Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
  NCT07468903 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: Male · California: Los Angeles
• Focal Therapy for Localized Prostate Cancer
  NCT06270043 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · California: La Jolla
• Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
  NCT04812366 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Sacramento
• Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
  NCT06500169 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years to 85 Years · Sex: Male · California: Los Angeles
• Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
  NCT06615752 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• HIFU for Focal Ablation of Prostate Tissue: An Observational Study
  NCT03620786 · Phase: Not specified · Ages: 40 Years to 85 Years · Sex: Male · California: Los Angeles
• High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
  NCT07223385 · Phase: Phase 2 · Ages: 45 Years and older · Sex: Male · California: Los Angeles
• High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
  NCT04945642 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
  NCT06067269 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone
  NCT06384222 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco